Gut bacteria swap explored as MS treatment in tiny trial
NCT ID NCT03594487
First seen Feb 03, 2026 · Last updated May 11, 2026 · Updated 15 times
Summary
This early-stage study tested whether a fecal transplant (donated stool given via colonoscopy) is safe and tolerable for people with relapsing-remitting multiple sclerosis. Only 5 participants were enrolled, and the study was terminated early. The goal was to see if changing gut bacteria could affect the immune system and MS activity, but no conclusions can be drawn due to the small size and early termination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF Multiple Sclerosis Center
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.